Francis G S, Chu C
Department of Medicine, University of Minnesota Medical School, Minneapolis 55455.
Curr Opin Cardiol. 1994 May;9(3):280-8. doi: 10.1097/00001573-199405000-00004.
The past few years have witnessed an extraordinary number of important developments in the study of compensatory and maladaptive responses to cardiac dysfunction. It now seems clear that the process whereby the heart remodels in response to left ventricular injury is of paramount importance in the expression of clinical heart failure. There have been parallel attempts by basic scientists and clinical investigators to understand better the fundamental biologic processes that underlie remodeling and to assess numerous new treatments--especially angiotensin-converting enzyme inhibitors. A general consensus seems to be emerging that holds that the response of the heart to acute injury includes a number of highly compensatory and adaptive mechanisms that ultimately become maladaptive and contribute to cardiomegaly and severe congestive heart failure. Such mechanisms undoubtedly include local and systemic release of cytokines, peptides, and neurohormones, and altered loading conditions leading to unusual mechanical forces on cardiac myocytes and other cells of the heart. At the organ level there is hypertrophy, dilatation and growth of the interstitium. Preliminary evidence also suggests there may be some "remodeling" at the cardiac myocyte level. Reduction in peripheral vasodilator reserve is seen in experimental animal models of heart failure. Patients with heart failure also develop an endothelial-dependent form of peripheral vascular dysfunction expressed clinically as an attenuated ability to dilate in response to such stimuli as acetylcholine. The transition point whereby these myocardial and peripheral vascular abnormalities become clearly dysfunctional and contribute toward the full clinical expression of heart failure remains to be further investigated.
在对心脏功能障碍的代偿性和适应不良性反应的研究中,过去几年见证了大量重要进展。现在似乎很清楚,心脏对左心室损伤作出重塑反应的过程在临床心力衰竭的表现中至关重要。基础科学家和临床研究人员同时进行了尝试,以更好地理解重塑背后的基本生物学过程,并评估众多新疗法——尤其是血管紧张素转换酶抑制剂。一种普遍的共识似乎正在形成,即心脏对急性损伤的反应包括一些高度代偿性和适应性机制,这些机制最终会变得适应不良,并导致心脏肥大和严重的充血性心力衰竭。这些机制无疑包括细胞因子、肽和神经激素的局部和全身释放,以及负荷条件的改变,从而导致心肌细胞和心脏其他细胞受到异常的机械力作用。在器官水平上,有间质的肥大、扩张和生长。初步证据还表明,在心肌细胞水平可能存在一些“重塑”。在心力衰竭的实验动物模型中可以看到外周血管舒张储备的降低。心力衰竭患者还会出现一种内皮依赖性的外周血管功能障碍,临床上表现为对乙酰胆碱等刺激的舒张能力减弱。这些心肌和外周血管异常明显功能失调并导致心力衰竭完全临床症状出现的转折点仍有待进一步研究。